Relieves symptoms associated with acute and recurrent diabetic gastric stasis. ANDA 73118, held by Hospira. Metoclopramide Hydrochloride.
As of Nov 21, 2026, ANDA 73118 (Metoclopramide Hydrochloride), held by Hospira, was first approved by FDA on Jan 17, 1991, with 17 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Diabetic Gastroparesis (Diabetic Gastric Stasis) Metoclopramide is indicated for the relief of symptoms associated with acute and recurrent diabetic gastric stasis. The Prevention of Nausea and Vomiting Associated with Emetogenic Cancer Chemotherapy Metoclopramide Injection, USP is indicated for the prophylaxis of vomiting associated with emetogenic cancer chemotherapy. The Prevention of Postoperative Nausea and Vomiting Metoclopramide Injection, USP is indicated for the prophylaxis of postoperative nausea and vomiting in those circumstances where nasogastric suction is undesirable.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 17, 1991 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metoclopramide HydrochlorideEQ 5MG BASE/ML · injectable;injection | Metoclopramide Hydrochloride | Rx |
| Jun 2, 2015 | Supplement 26Labeling | Approved | None posted |
| Jun 2, 2015 | Supplement 28Labeling · Standard review | Approved | None posted |
| Apr 3, 2006 | Supplement 18Labeling | Approved | None posted |
| May 5, 2003 | Supplement 16Labeling | Approved | None posted |
| Dec 9, 2002 | Supplement 15Labeling | Approved | None posted |
| Oct 25, 2002 | Supplement 14Manufacturing | Approved | None posted |
| Feb 1, 2002 | Supplement 13Labeling | Approved | None posted |
| Mar 22, 2001 | Supplement 11Manufacturing | Approved | None posted |
| Mar 22, 2001 | Supplement 12Manufacturing | Approved | None posted |
| Jan 7, 2000 | Supplement 8Manufacturing | Approved | None posted |
| Jan 7, 2000 | Supplement 9Labeling | Approved | None posted |
| Sep 13, 1999 | Supplement 10Labeling | Approved | None posted |
| Nov 25, 1997 | Supplement 7Labeling | Approved | None posted |
| Oct 22, 1996 | Supplement 4Manufacturing | Approved | None posted |
| Oct 3, 1996 | Supplement 5Manufacturing | Approved | None posted |
| Feb 7, 1996 | Supplement 1Manufacturing | Approved | None posted |
| Nov 30, 1995 | Supplement 2Labeling | Approved | None posted |
| Jan 17, 1991 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters